These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28942130)

  • 21. Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse classic and non-classic lipopolysaccharides.
    Lapaque N; Takeuchi O; Corrales F; Akira S; Moriyon I; Howard JC; Gorvel JP
    Cell Microbiol; 2006 Mar; 8(3):401-13. PubMed ID: 16469053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kdo2 -lipid A: structural diversity and impact on immunopharmacology.
    Wang X; Quinn PJ; Yan A
    Biol Rev Camb Philos Soc; 2015 May; 90(2):408-27. PubMed ID: 24838025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection.
    Maldonado RF; Sá-Correia I; Valvano MA
    FEMS Microbiol Rev; 2016 Jul; 40(4):480-93. PubMed ID: 27075488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosynthesis and export of bacterial lipopolysaccharides.
    Whitfield C; Trent MS
    Annu Rev Biochem; 2014; 83():99-128. PubMed ID: 24580642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.
    Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K
    Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses.
    Yi YS
    Immunology; 2017 Oct; 152(2):207-217. PubMed ID: 28695629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function and Biogenesis of Lipopolysaccharides.
    Bertani B; Ruiz N
    EcoSal Plus; 2018 Aug; 8(1):. PubMed ID: 30066669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics.
    Johnson DA
    Curr Top Med Chem; 2008; 8(2):64-79. PubMed ID: 18289078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxins: lipopolysaccharides of gram-negative bacteria.
    Wang X; Quinn PJ
    Subcell Biochem; 2010; 53():3-25. PubMed ID: 20593260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria.
    Nys M; Damas P; Damas F; Joassin L; Demonty J
    Med Microbiol Immunol; 1987; 176(5):257-71. PubMed ID: 3657701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kdo2-lipid A modification in gram-negative bacteria--a review].
    Wang X
    Wei Sheng Wu Xue Bao; 2013 Feb; 53(2):111-7. PubMed ID: 23627103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human monoclonal antibodies to glycolipid A that exhibit complement species-specific effector functions.
    Winkelhake JL; Gauny SS; Senyk G; Piazza D; Stevens P
    J Infect Dis; 1992 Jan; 165(1):26-33. PubMed ID: 1727895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acylation and phosphorylation pattern of lipid A from Xanthomonas campestris strongly influence its ability to trigger the innate immune response in Arabidopsis.
    Silipo A; Sturiale L; Garozzo D; Erbs G; Jensen TT; Lanzetta R; Dow JM; Parrilli M; Newman MA; Molinaro A
    Chembiochem; 2008 Apr; 9(6):896-904. PubMed ID: 18350528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants.
    Alving CR
    Immunobiology; 1993 Apr; 187(3-5):430-46. PubMed ID: 8330907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OMV Vaccines and the Role of TLR Agonists in Immune Response.
    Mancini F; Rossi O; Necchi F; Micoli F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gram-negative virulent bacterial lipopolysaccharide: role in infection and immunity].
    Vorobév AA; Borisova EV; Borisov VA
    Vestn Ross Akad Med Nauk; 1997; (3):10-3. PubMed ID: 9181847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbe-associated molecular patterns in innate immunity: Extraction and chemical analysis of gram-negative bacterial lipopolysaccharides.
    De Castro C; Parrilli M; Holst O; Molinaro A
    Methods Enzymol; 2010; 480():89-115. PubMed ID: 20816206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fundamentals of endotoxin structure and function.
    Bishop RE
    Contrib Microbiol; 2005; 12():1-27. PubMed ID: 15496774
    [No Abstract]   [Full Text] [Related]  

  • 39. Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii.
    Cian MB; Giordano NP; Mettlach JA; Minor KE; Dalebroux ZD
    J Vis Exp; 2020 Apr; (158):. PubMed ID: 32338649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement activation by bacterial surface glycolipids: a study with planar bilayer membranes.
    Münstermann M; Wiese A; Brandenburg K; Zähringer U; Brade L; Kawahara K; Seydel U
    J Membr Biol; 1999 Feb; 167(3):223-32. PubMed ID: 9929374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.